Effectiveness of antipsychotics: Is the CATIE trial a tsunami?

Canadian Family Physician

Volumn 53, Issue 1, 2007, Pages 97-98

  Stip, Emmanuel ^a   Anselmo, Karyne ^a  

^a CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; PHENOTHIAZINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG WITHDRAWAL; EXTRAPYRAMIDAL SYNDROME; GENERAL PRACTITIONER; HUMAN; MEDICAL LITERATURE; OUTCOME ASSESSMENT; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SCHIZOPHRENIA; SHORT SURVEY; SIDE EFFECT; TARDIVE DYSKINESIA; TRIACYLGLYCEROL BLOOD LEVEL; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

EID: 33846522296     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (8)

1. Stip E. Happy birthday neuroleptics! 50 years later: la folie du doute. Eur Psychiatry 2002;17(3):115-9.
2. Jones PB, Davis L, Barnes TR, Murray RM, Dunn G, Hayhurst KP, et al. Randomised controlled trial of effect on quality of life of prescription of SGA versus FGA antipsychotic drugs in schizophrenia. Schizo Bull 2005;31(2):489.
3. Citrome L, Volavka J. Optimal dosing of atypical antipsychotics in adults: a review of the current evidence. Harv Rev Psychiatry 2002;10:280-91.
4. Geddes J, Freemantle N, Harrison P, Bebbington P. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ 2000;321:1371-6.
5. Davis JM, Chen N, Glick ID. A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry 2003;60:553-64.
6. Hartung B, Wada M, Laux G, Leucht S. Perphenazine for schizophrenia. Cochrane Database Syst Rev 2005;25(1):CD003443.
7. Canadian Psychiatric Association. Clinical Practice Guidelines. Treatment for schizophrenia. Can J Psychiatry 2005;50(Suppl 1):7S-57S.
8. Stip E. Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics. J Psychiatry Neurosci 2000;25(2):137-53.